tutor2u | New Leadership at GSK Means Changes to the Product Portfolio

In the News

New Leadership at GSK Means Changes to the Product Portfolio

Jim Riley

26th July 2017

The new CEO of pharmaceutical multinational GSK, Emma Walmsley, has completed her "strategic review". As usually happens when such a review is carried out by a new CEO, the result is changes to the shape of the business.

The Independent reports here that Walmsley and her Board have decided to sell more than 130 of its brands as part of a strategy of greater focus on core markets and cost reductions to improve profitability.

The FT reports that GSK will also cut more than 30 research and development programmes and consider the sale of its rare diseases unit. The effect will be to allow GSK to better focus its R&D investment on treatments for respiratory conditions, HIV and infectious diseases - all identified as key growth opportunities.

GSK aims to reduce total annual operating costs by £1bn by 2020.

Jim Riley

Jim co-founded tutor2u alongside his twin brother Geoff! Jim is a well-known Business writer and presenter as well as being one of the UK's leading educational technology entrepreneurs.

Recommended

Exam support for 2022

Online Grade Booster Courses for A-Level Exams in May & June 2022

Exam technique, advance information support, live revision and more from the tutor2u subject specialist teams

Enrol now

© 2002-2022 Tutor2u Limited. Company Reg no: 04489574. VAT reg no 816865400.